Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1

Overview of attention for article published in Journal for Immunotherapy of Cancer, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)

Mentioned by

news: 8 news outlets
twitter: 10 tweeters

patent: 1 patent

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 76 Mendeley

Summary News Twitter Patents Dimensions citations

So far, Dimensions has found 45 publications that cite this research output.

45

The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.

The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1

Article in Viruses (June 2022)

Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers

Article in Cancers (June 2022)

Oncolytic viral vectors in the era of diversified cancer therapy: from preclinical to clinical

Article in Clinical and Translational Oncology (May 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.